Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood Collection Tube Assessment for Jatenzo
NCT03973840Phase 1Completed
- Sponsor
- Clarus Therapeutics
- Start
- Jul 2018
- Primary completion
- Jul 2018
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of testosterone undecanoate in Hypogonadism, sponsored by Clarus Therapeutics. Primary endpoint: Rate of post-collection TU-to-testosterone conversion in 3 types of collection tubes at 8 days. Started Jul 2018; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT03973840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03973840.